Antares Pharma, Inc. · Ewing, NJ United States (NYSE Amex: AIS)
Key Antares Pharma, Inc. Financials
| Company Type | Public -(NYSE Amex: AIS) Headquarters |
|---|---|
| Fiscal Year-End | December |
| Sales (mil.) | $1.2 |
| 2010 Employees | 21 |
Antares Pharma, Inc. Stock Quote (NYSE Amex: AIS)
| Latest 02/15/12 16:00:45 EST | Change ($) | Change (%) | High | Low |
|---|---|---|---|---|
| $2.51 | 0.000 | 0.000 | $0.00 | $0.00 |
Quotes delayed 15 minutes for NASDAQ, 20 minues for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions. |
Antares Pharma, Inc. Income Statement
| Dec 93 | Dec 92 | Dec 91 | |
| Revenue | 1.2 | 1.1 | 1.1 |
| Cost of Goods Sold | -- | -- | -- |
| Gross Profit | 1.2 | 1.1 | 1.1 |
| Gross Profit Margin | -- | -- | -- |
| SG&A Expense | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- |
| Operating Income | -- | -- | -- |
| Operating Margin | --% | --% | --% |
| Nonoperating Income | -- | -- | -- |
| Nonoperating Expenses | -- | -- | -- |
| Income Before Taxes | -- | -- | -- |
| Income Taxes | -- | -- | -- |
| Net Income After Taxes | 0.0 | 0.0 | 0.0 |
| Continuing Operations | -- | -- | -- |
| Discontinued Operations | -- | -- | -- |
| Total Operations | -- | -- | -- |
| Total Net Income | (0.5) | (0.2) | (0.1) |
| Net Profit Margin | -42.4% | -14.5% | -9.8% |
| Diluted EPS from Total Net Income | -- | -- | -- |
| Dividends per Share | -- | -- | -- |
All amounts in millions of US Dollars except per share amounts.
Antares Pharma, Inc. Balance Sheet
| Assets | Dec 93 | Dec 92 | Dec 91 |
| Current Assets | |||
| Cash | -- | -- | -- |
| Net Receivables | -- | -- | -- |
| Inventories | -- | -- | -- |
| Other Current Assets | -- | -- | -- |
| Total Current Assets | -- | -- | -- |
| Net Fixed Assets | -- | -- | -- |
| Other Noncurrent Assets | -- | -- | -- |
| Total Assets | -- | -- | -- |
| Liabilities | Dec 93 | Dec 92 | Dec 91 |
| Current Liabilities | |||
| Accounts Payable | -- | -- | -- |
| Short-Term Debt | -- | -- | -- |
| Other Current Liabilities | -- | -- | -- |
| Total Current Liabilities | -- | -- | -- |
| Long-Term Debt | -- | -- | -- |
| Other Noncurrent Liabilities | -- | -- | -- |
| Total Liabilities | -- | -- | -- |
| Shareholder's Equity | |||
| Preferred Stock Equity | -- | -- | -- |
| Common Stock Equity | -- | -- | -- |
| Total Equity | -- | -- | -- |
| Shares Outstanding (thou.) | -- | -- | -- |
All amounts in millions of US Dollars except per share amounts.
Antares Pharma, Inc. Cash Flow Statement
| Dec 93 | Dec 92 | Dec 91 | |
| Net Operating Cash Flow | -- | -- | -- |
| Net Investing Cash Flow | -- | -- | -- |
| Net Financing Cash Flow | |||
| Net Change in Cash | |||
| Depreciation & Amortization | |||
| Capital Expenditures | |||
| Cash Dividends Paid |
All amounts in millions of US Dollars except per share amounts.